-
Je něco špatně v tomto záznamu ?
Acetylated deoxycholic (DCA) and cholic (CA) acids are potent ligands of pregnane X (PXR) receptor
A. Carazo, L. Hyrsova, J. Dusek, H. Chodounska, A. Horvatova, K. Berka, V. Bazgier, H. Gan-Schreier, W. Chamulitrat, E. Kudova, P. Pavek,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- acetylace MeSH
- buněčné kultury MeSH
- buňky Hep G2 MeSH
- cytochrom P-450 CYP3A genetika MeSH
- cytochrom P450 CYP2B6 genetika MeSH
- hepatocyty účinky léků enzymologie metabolismus MeSH
- kyselina cholová chemie metabolismus farmakologie MeSH
- kyselina deoxycholová chemie metabolismus farmakologie MeSH
- lidé MeSH
- ligandy MeSH
- myši MeSH
- oxidace-redukce MeSH
- P-glykoprotein genetika MeSH
- plazmidy MeSH
- receptory cytoplazmatické a nukleární chemie genetika metabolismus MeSH
- receptory kalcitriolu chemie genetika metabolismus MeSH
- reportérové geny MeSH
- simulace molekulového dockingu MeSH
- steroidní receptory chemie genetika metabolismus MeSH
- techniky dvojhybridového systému MeSH
- transfekce MeSH
- vazba proteinů MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
The Pregnane X (PXR), Vitamin D (VDR) and Farnesoid X (FXR) nuclear receptors have been shown to be receptors of bile acids controlling their detoxification or synthesis. Chenodeoxycholic (CDCA) and lithocholic (LCA) acids are ligands of FXR and VDR, respectively, whereas 3-keto and acetylated derivates of LCA have been described as ligands for all three receptors. In this study, we hypothesized that oxidation or acetylation at position 3, 7 and 12 of bile acids DCA (deoxycholic acid), LCA, CA (cholic acid), and CDCA by detoxification enzymes or microbiome may have an effect on the interactions with bile acid nuclear receptors. We employed reporter gene assays in HepG2 cells, the TR-FRET assay with recombinant PXR and RT-PCR to study the effects of acetylated and keto bile acids on the nuclear receptors activation and their target gene expression in differentiated hepatic HepaRG cells. We demonstrate that the DCA 3,12-diacetate and CA 3,7,12-triacetate derivatives are ligands of PXR and DCA 3,12-diacetate induces PXR target genes such as CYP3A4, CYP2B6 and ABCB1/MDR1. In conclusion, we found that acetylated DCA and CA are potent ligands of PXR. Whether the acetylated bile acid derivatives are novel endogenous ligands of PXR with detoxification or physiological functions should be further studied in ongoing experiments.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013385
- 003
- CZ-PrNML
- 005
- 20170418110328.0
- 007
- ta
- 008
- 170413s2017 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.toxlet.2016.11.013 $2 doi
- 035 __
- $a (PubMed)27871908
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Carazo, Alejandro $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, Hradec Kralove CZ500 05, Czechia.
- 245 10
- $a Acetylated deoxycholic (DCA) and cholic (CA) acids are potent ligands of pregnane X (PXR) receptor / $c A. Carazo, L. Hyrsova, J. Dusek, H. Chodounska, A. Horvatova, K. Berka, V. Bazgier, H. Gan-Schreier, W. Chamulitrat, E. Kudova, P. Pavek,
- 520 9_
- $a The Pregnane X (PXR), Vitamin D (VDR) and Farnesoid X (FXR) nuclear receptors have been shown to be receptors of bile acids controlling their detoxification or synthesis. Chenodeoxycholic (CDCA) and lithocholic (LCA) acids are ligands of FXR and VDR, respectively, whereas 3-keto and acetylated derivates of LCA have been described as ligands for all three receptors. In this study, we hypothesized that oxidation or acetylation at position 3, 7 and 12 of bile acids DCA (deoxycholic acid), LCA, CA (cholic acid), and CDCA by detoxification enzymes or microbiome may have an effect on the interactions with bile acid nuclear receptors. We employed reporter gene assays in HepG2 cells, the TR-FRET assay with recombinant PXR and RT-PCR to study the effects of acetylated and keto bile acids on the nuclear receptors activation and their target gene expression in differentiated hepatic HepaRG cells. We demonstrate that the DCA 3,12-diacetate and CA 3,7,12-triacetate derivatives are ligands of PXR and DCA 3,12-diacetate induces PXR target genes such as CYP3A4, CYP2B6 and ABCB1/MDR1. In conclusion, we found that acetylated DCA and CA are potent ligands of PXR. Whether the acetylated bile acid derivatives are novel endogenous ligands of PXR with detoxification or physiological functions should be further studied in ongoing experiments.
- 650 _2
- $a acetylace $7 D000107
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a buněčné kultury $7 D018929
- 650 _2
- $a kyselina cholová $x chemie $x metabolismus $x farmakologie $7 D019826
- 650 _2
- $a cytochrom P450 CYP2B6 $x genetika $7 D065702
- 650 _2
- $a cytochrom P-450 CYP3A $x genetika $7 D051544
- 650 _2
- $a kyselina deoxycholová $x chemie $x metabolismus $x farmakologie $7 D003840
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a reportérové geny $7 D017930
- 650 _2
- $a buňky Hep G2 $7 D056945
- 650 _2
- $a hepatocyty $x účinky léků $x enzymologie $x metabolismus $7 D022781
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a simulace molekulového dockingu $7 D062105
- 650 _2
- $a oxidace-redukce $7 D010084
- 650 _2
- $a P-glykoprotein $x genetika $7 D020168
- 650 _2
- $a plazmidy $7 D010957
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a receptory kalcitriolu $x chemie $x genetika $x metabolismus $7 D018167
- 650 _2
- $a receptory cytoplazmatické a nukleární $x chemie $x genetika $x metabolismus $7 D018160
- 650 _2
- $a steroidní receptory $x chemie $x genetika $x metabolismus $7 D011987
- 650 _2
- $a transfekce $7 D014162
- 650 _2
- $a techniky dvojhybridového systému $7 D020798
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hyrsova, Lucie $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, Hradec Kralove CZ500 05, Czechia.
- 700 1_
- $a Dusek, Jan $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, Hradec Kralove CZ500 05, Czechia.
- 700 1_
- $a Chodounska, Hana $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo náměstí 2, CZ160 00 Praha, Czechia.
- 700 1_
- $a Horvatova, Alzbeta $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, Hradec Kralove CZ500 05, Czechia.
- 700 1_
- $a Berka, Karel $u Regional Centre of Advanced Technologies and Materials, Department of Physical Chemistry, Palacky University in Olomouc, 17. listopadu 1131, Olomouc CZ779 00, Czechia.
- 700 1_
- $a Bazgier, Vaclav $u Regional Centre of Advanced Technologies and Materials, Department of Physical Chemistry, Palacky University in Olomouc, 17. listopadu 1131, Olomouc CZ779 00, Czechia.
- 700 1_
- $a Gan-Schreier, Hongying $u Department of Internal Medicine IV, Gastroenterology and Infectious Diseases, Im Neuenheimer Feld, Heidelberg, Germany.
- 700 1_
- $a Chamulitrat, Waleé $u Department of Internal Medicine IV, Gastroenterology and Infectious Diseases, Im Neuenheimer Feld, Heidelberg, Germany.
- 700 1_
- $a Kudova, Eva $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo náměstí 2, CZ160 00 Praha, Czechia.
- 700 1_
- $a Pavek, Petr $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, Hradec Kralove CZ500 05, Czechia. Electronic address: petr.pavek@faf.cuni.cz.
- 773 0_
- $w MED00004537 $t Toxicology letters $x 1879-3169 $g Roč. 265, č. - (2017), s. 86-96
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27871908 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170418110636 $b ABA008
- 999 __
- $a ok $b bmc $g 1199850 $s 974163
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 265 $c - $d 86-96 $e 20161118 $i 1879-3169 $m Toxicology letters $n Toxicol Lett $x MED00004537
- LZP __
- $a Pubmed-20170413